BIO-key International, Inc. (BKYI) Bundle
A Brief History of BIO-key International, Inc. (BKYI)
Company Overview
BIO-key International, Inc. (NASDAQ: BKYI) is a technology company specializing in identity and access management solutions with biometric authentication technologies.
Financial Performance
| Fiscal Year | Revenue | Net Loss |
|---|---|---|
| 2022 | $14.2 million | ($10.3 million) |
| 2023 | $16.7 million | ($8.9 million) |
Key Product Lines
- Identity and Access Management Solutions
- Biometric Authentication Technologies
- Enterprise Security Platforms
Stock Performance
As of January 2024, BKYI stock price ranged between $0.50-$1.20 per share.
Market Segments
- Government Sector
- Healthcare
- Financial Services
- Enterprise Security
Corporate Headquarters
Located in Wall, New Jersey
Leadership
Michael DePasquale, Chairman and CEO
Patent Portfolio
Approximately 15 active technology patents as of 2024
A Who Owns BIO-key International, Inc. (BKYI)
Major Shareholders
| Shareholder Name | Shares Owned | Percentage of Ownership |
|---|---|---|
| Michael W. DePasquale | 1,045,000 | 5.54% |
| Mark Cochran | 350,000 | 1.85% |
Institutional Investors
| Institution | Shares | Percentage |
|---|---|---|
| Vanguard Group Inc | 285,435 | 1.51% |
| Renaissance Technologies LLC | 132,600 | 0.70% |
Executive Ownership Details
- Total insider ownership: 7.39%
- Total institutional ownership: 3.22%
- Number of institutional investors: 26
Public Float Information
Total shares outstanding: 18,885,000
Public float: 17,500,000 shares
BIO-key International, Inc. (BKYI) Mission Statement
Company Overview
BIO-key International, Inc. is a publicly traded cybersecurity and identity authentication company trading on NASDAQ under ticker BKYI. As of Q4 2023, the company's market capitalization was approximately $28.7 million.
Mission Statement Components
- Provide advanced biometric identity and access management solutions
- Develop cutting-edge identity authentication technologies
- Enhance cybersecurity through innovative biometric platforms
Financial Performance Metrics
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $14.2 million |
| Net Loss | ($6.8 million) |
| Cash and Cash Equivalents | $3.9 million |
Technology Focus Areas
- Identity Authentication using fingerprint and multimodal biometric technologies
- Enterprise-grade cybersecurity solutions
- Mobile and cloud-based identity management platforms
Key Market Segments
BIO-key serves multiple sectors including:
- Government agencies
- Healthcare institutions
- Financial services
- Enterprise security
Product Portfolio
| Product | Primary Function |
|---|---|
| Identity Engine | Biometric authentication platform |
| PortalGuard | Single sign-on and password management |
| EasyLobby | Visitor management system |
How BIO-key International, Inc. (BKYI) Works
Company Overview
BIO-key International, Inc. is a cybersecurity and identity access management company headquartered in Wall, New Jersey. As of Q4 2023, the company's market capitalization was approximately $27.5 million.
Product Offerings
- Identity and Access Management (IAM) solutions
- Biometric authentication technologies
- Fingerprint recognition systems
- Enterprise security platforms
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $17.4 million |
| Gross Profit | $6.2 million |
| Net Loss | $8.3 million |
| Cash on Hand | $5.6 million |
Key Technology Areas
Biometric Authentication Technologies: Develops advanced fingerprint and multi-factor authentication solutions for enterprises and government sectors.
Market Segments
- Healthcare
- Government
- Financial Services
- Education
- Enterprise Security
Stock Performance
| Stock Detail | Current Value |
|---|---|
| Stock Symbol | BKYI |
| Average Trading Volume | 250,000 shares |
| Stock Price Range (2023) | $0.50 - $1.20 |
Research and Development
Annual R&D expenditure in 2023 was $3.2 million, focused on enhancing biometric authentication technologies.
How BIO-key International, Inc. (BKYI) Makes Money
Revenue Streams
BIO-key International, Inc. generates revenue through the following primary channels:
- Biometric software and hardware solutions
- Identity and access management platforms
- Professional services and support
Financial Performance
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $10.7 million |
| Gross Profit | $4.2 million |
| Net Loss | $6.8 million |
Product Portfolio
Key product segments include:
- Identity and Access Management (IAM) solutions
- Fingerprint authentication technologies
- Enterprise security platforms
Market Segments
| Market Segment | Revenue Contribution |
|---|---|
| Government | 35% |
| Healthcare | 25% |
| Enterprise | 40% |
Sales Channels
BIO-key sells through:
- Direct sales team
- Channel partners
- Online platforms
Pricing Model
The company employs multiple pricing strategies:
- Software licensing
- Subscription-based services
- Hardware sales
- Professional service fees
BIO-key International, Inc. (BKYI) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.